Related Experiment Video
Updated: May 23, 2026
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Translational research in neurology: dementia
1Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center, New York, New York, USA. lh456@columbia.edu
Archives of Neurology
|April 5, 2012
Summary
Translational research advances dementia diagnosis and treatment by developing molecular biomarkers and targeted therapies. These innovations improve early detection and guide the creation of disease-modifying drugs for neurodegenerative conditions like Alzheimer disease.
Area of Science:
- Neuroscience
- Pathology
- Pharmacology
Background:
- Dementia disorders are diagnosed using clinicopathological criteria.
- Molecular insights from various research methods have improved dementia diagnosis.
- Translational research bridges basic science and clinical application in neurodegeneration.
Purpose of the Study:
- To review the application of translational research in dementia diagnosis and treatment.
- To highlight the role of molecular understanding in developing new therapies.
- To discuss advancements in diagnostic biomarkers and targeted treatment strategies.
Main Methods:
- Review of immunohistochemical studies, biochemical investigations, and genetic approaches.
- Analysis of animal models of neurodegeneration.
- Examination of translational research in diagnostic biomarker development and therapeutic interventions.
Main Results:
- Biomarker development has led to advanced imaging and biochemical diagnostic methods, particularly for Alzheimer disease.
- New diagnostic criteria are emerging based on molecular techniques.
- Translational research is driving the development of targeted, disease-modifying therapies.
Conclusions:
- Translational research is crucial for improving dementia diagnosis and treatment.
- Molecular biomarkers aid in early detection and monitoring disease activity.
- Targeted therapies based on understanding disease pathogenesis offer new hope for slowing neurodegeneration.
More Related Videos
06:14Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
Published on: May 8, 2018
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...